New needle probe aims to spot prostate cancer without extra tissue samples

NCT ID NCT05965180

Recruiting now Knowledge-focused Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new fine needle probe that uses light and sound (photoacoustic technology) to measure prostate tissue during a standard biopsy. The probe is inserted like a regular biopsy needle but does not remove tissue. Researchers want to see if it can reliably tell the difference between healthy and cancerous areas. The study involves 50 men scheduled for a prostate biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fine needle photoacoustic probe (device)
What this could lead to: If successful, this could lead to a more accurate way to detect prostate cancer during biopsy without needing extra tissue samples.
What could go wrong: This is a very early, small study (50 people) testing only if the device can get reliable readings. It may not show any benefit for patients, and technical failures could stop the trial early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

University of Michigan Rogel Cancer Center
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.